SWOG clinical trial number

S9304A-ICSC

Investigation of Thioredoxin-1 Family Protein Expression in Rectal Cancer

Closed

Abbreviated Title

Ancillary

Research committees

Gastrointestinal Cancer

Other Clinical Trials

SWOG Clinical Trial Number

CTSU/A022101

A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)

Research Committee(s)

Gastrointestinal Cancer

Activated

01/10/2023

Open

SWOG Clinical Trial Number

S2107

Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer

Research Committee(s)

Gastrointestinal Cancer

Activated

06/06/2022

Accrual

73%

Open

Phase

SWOG Clinical Trial Number

S2104

A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors

Research Committee(s)

Gastrointestinal Cancer

Activated

10/14/2021

Accrual

27%

Open

Phase